Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Derksen

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|May 25, 2026
Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosisLiza M Y Gelissen, Stefan P H van den Berg, Alyssa A Toorop, et al.
Nature Communications|October 14, 2022
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagementMaximilian Brinkhaus, Erwin Pannecoucke, Elvera J van der Kooi, et al.
Clinical and Experimental Rheumatology|September 10, 2019
The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisationLea C Berkhout, Erik H Vogelzang, Margreet M Hart, et al.
Molecular Immunology|September 18, 2020
Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b bindingA Robin Temming, Arthur E H Bentlage, Steven W de Taeye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2023
The Influence of Human IgG Subclass and Allotype on Complement ActivationTimon Damelang, Steven W de Taeye, Rosa Rentenaar, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Annals of the Rheumatic Diseases|June 28, 2018
Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodiesKarin A van Schie, Simone Kruithof, Pleuni Ooijevaar-de Heer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
Adaptive antibody diversification through <i>N</i>-linked glycosylation of the immunoglobulin variable regionFleur S van de Bovenkamp, Ninotska I L Derksen, Pleuni Ooijevaar-de Heer, et al.
Ebiomedicine|June 25, 2022
Immunoassay for quantification of antigen-specific IgG fucosylationTonći Šuštić, Julie Van Coillie, Mads Delbo Larsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2023
CD5L is a canonical component of circulatory IgMNienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|May 25, 2026
Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosisLiza M Y Gelissen, Stefan P H van den Berg, Alyssa A Toorop, et al.
Nature Communications|October 14, 2022
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagementMaximilian Brinkhaus, Erwin Pannecoucke, Elvera J van der Kooi, et al.
Clinical and Experimental Rheumatology|September 10, 2019
The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisationLea C Berkhout, Erik H Vogelzang, Margreet M Hart, et al.
Molecular Immunology|September 18, 2020
Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b bindingA Robin Temming, Arthur E H Bentlage, Steven W de Taeye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2023
The Influence of Human IgG Subclass and Allotype on Complement ActivationTimon Damelang, Steven W de Taeye, Rosa Rentenaar, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Annals of the Rheumatic Diseases|June 28, 2018
Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodiesKarin A van Schie, Simone Kruithof, Pleuni Ooijevaar-de Heer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2018
Adaptive antibody diversification through <i>N</i>-linked glycosylation of the immunoglobulin variable regionFleur S van de Bovenkamp, Ninotska I L Derksen, Pleuni Ooijevaar-de Heer, et al.
Ebiomedicine|June 25, 2022
Immunoassay for quantification of antigen-specific IgG fucosylationTonći Šuštić, Julie Van Coillie, Mads Delbo Larsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2023
CD5L is a canonical component of circulatory IgMNienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Pageof 8